INTEGRA LIFESCIENCES HOLDINGS CORPORATION Integra LifeSciences Holdings Corporation
Equities
IART
US4579852082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.91 USD | -0.68% |
|
-14.63% | -42.80% |
Presenter SpeechRobert Marcus (Analysts)Good afternoon. I'm Robbie Marcus, the med tech analys...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.
Calendar
09:00am
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
24.91
USD
Average target price
33.8
USD
Spread / Average Target
+35.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -42.80% | 1.97B | |
| -4.66% | 185B | |
| -1.01% | 109B | |
| -4.20% | 68.54B | |
| +2.68% | 51.74B | |
| +9.12% | 45.22B | |
| +3.49% | 41.74B | |
| +4.13% | 26.83B | |
| +3.31% | 26.69B | |
| +12.96% | 25.63B |
- Stock Market
- Equities
- IART Stock
- News Integra LifeSciences Holdings Corporation
- Transcript : Integra LifeSciences Holdings Corporation Presents at JPMorgan 40th Annual Healthcare Conference, Jan-12-2022 04